Evidence map›Paper›PMID 32577128›Full record

ArticleBMC proceedings2020

Prevention and control of HPV infection and HPV-related cancers in Colombia- a meeting report.

Alex Vorsters, Francesc Xavier Bosch, Paolo Bonanni, Eduardo L Franco, Marc Baay, Clarissa Simas, Dur-E-Nayab Waheed, Carlos Castro, Raul Murillo, Lina Trujillo and 2 more

Abstract read
In one paragraph

Article in BMC proceedings, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alex VorstersCentre for Evaluation of Vaccination, Vaccine and Infectious Diseases Institute, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Antwerp, Belgium.
Francesc Xavier BoschCancer Epidemiology Research Program, IDIBELL, Catalan Institute of Oncology, L'Hospitalet De Llobregat, Barcelona, Spain.
Paolo BonanniUniversity of Florence, Health Sciences, Florence, Italy.
Eduardo L FrancoDepartment of Oncology, McGill University, Montreal, Canada.
Marc BaayP95, Epidemiology and Pharmacovigilance Consulting and Services, Leuven, Belgium.
Clarissa SimasInfectious Disease and Epidemiology (IDE), London School of Hygiene and Tropical Medicine, London, UK.
Dur-E-Nayab WaheedCentre for Evaluation of Vaccination, Vaccine and Infectious Diseases Institute, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Antwerp, Belgium.
Carlos CastroColombian League against Cancer Bogota, Bogota, Colombia.
Raul MurilloCentro Javeriano de Oncología, Hospital Universitario San Ignacio, Bogota, Colombia.
Lina TrujilloInstituto Nacional de Cancerología, Bogota, Colombia.
Carolina WiesnerInstituto Nacional de Cancerología, Bogota, Colombia.
Nubia MuñozInstituto Nacional de Cancerología, Bogota, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Human Papillomavirus (HPV) Prevention and Control Board is an independent multidisciplinary board of international experts that disseminates relevant information on HPV to a broad array of stakeholders and provides guidance on strategic, technical and policy issues in the implementation of HPV control programs. In response to drastic drop of vaccine coverage following the adverse event crisis in Carmen del Bolivar, Colombia, the HPV Prevention and Control Board in collaboration with the Colombian National Cancer Institute and Colombian League Against Cancer convened a meeting in Bogota, Columbia (November 2018). The goal of the meeting was to bring together national and international group of experts to report the disease burden, epidemiology and surveillance of HPV and HPV-related cancers, to discuss the successes and especially the challenges of HPV vaccination and screening in Colombia, as well as the lessons learnt from neighbouring countries. The meeting provided a platform to confer various stakeholder's perspectives, including the role of the Colombian healthcare system and to catalyse various parts of the public health community in Colombia into effective action. The conclusion of the meeting included following suggestions to strengthen HPV prevention and control: 1) Re-introducing school-based vaccine programs, 2) Integrating primary and secondary prevention programs, 3) Developing an innovative crisis communication plan targeting healthcare workers, teachers and general population, 4) Building trust through efficient and timely communication, 5) Building strong relationship with media to ensure a stable vaccination campaign support, and 6) Promoting empathy among healthcare professionals towards patients to build trust and communicate effectively.

Indexed as

Cervical cancer preventionHPVHuman papilloma virusScreeningVaccination

Identifiers

PMID32577128
PMCPMC7307134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.